Sunday, March 29, 2020

Strides Pharma Science receives EIR for Bengaluru facility from USFDA

Strides Pharma Science receives EIR for Bengaluru facility from USFDA The inspection by the US Food and Drug Administration (USFDA) was related to specific extended release applications made from the site. Receipt of EIR confirms the successful closure of the inspections, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3azrdms
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

What made Putin sell 22,000 kg gold from Russia this year?

Russia’s central bank has sold 21.8 tonnes or 22,000 kilograms of gold so far in 2026 to help fund the country’s widening budget deficit, wh...